PortfoliosLab logoPortfoliosLab logo
VXUS vs. ENVB
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

VXUS vs. ENVB - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Vanguard Total International Stock ETF (VXUS) and Enveric Biosciences Inc (ENVB). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, VXUS achieves a 15.42% return, which is significantly higher than ENVB's -59.23% return. Over the past 10 years, VXUS has outperformed ENVB with an annualized return of 10.23%, while ENVB has yielded a comparatively lower -74.86% annualized return.


VXUS

1D
1.52%
1M
4.66%
YTD
15.42%
6M
16.87%
1Y
32.10%
3Y*
18.53%
5Y*
8.83%
10Y*
10.23%

ENVB

1D
-3.27%
1M
-34.22%
YTD
-59.23%
6M
-72.39%
1Y
-89.81%
3Y*
-87.52%
5Y*
-85.10%
10Y*
-74.86%
*Multi-year figures are annualized to reflect compound growth (CAGR)

VXUS vs. ENVB - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
VXUS
Vanguard Total International Stock ETF
15.42%32.35%5.08%15.86%-16.08%8.98%10.66%21.75%-14.43%27.46%
ENVB
Enveric Biosciences Inc
-59.23%-94.37%-72.43%-37.50%-95.53%-37.16%-34.51%-48.17%-94.37%-52.38%

Correlation

The correlation between VXUS and ENVB is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.19

Correlation (3Y)
Calculated over the trailing 3-year period

0.19

Correlation (5Y)
Calculated over the trailing 5-year period

0.24

Correlation (10Y)
Calculated over the trailing 10-year period

0.20

Correlation (All Time)
Calculated using the full available price history since Jan 4, 2016

0.19

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

VXUS vs. ENVB — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VXUS
VXUS Risk / Return Rank: 6767
Overall Rank
VXUS Sharpe Ratio Rank: 6969
Sharpe Ratio Rank
VXUS Sortino Ratio Rank: 6767
Sortino Ratio Rank
VXUS Omega Ratio Rank: 7070
Omega Ratio Rank
VXUS Calmar Ratio Rank: 6363
Calmar Ratio Rank
VXUS Martin Ratio Rank: 6767
Martin Ratio Rank

ENVB
ENVB Risk / Return Rank: 1111
Overall Rank
ENVB Sharpe Ratio Rank: 1919
Sharpe Ratio Rank
ENVB Sortino Ratio Rank: 1212
Sortino Ratio Rank
ENVB Omega Ratio Rank: 1212
Omega Ratio Rank
ENVB Calmar Ratio Rank: 22
Calmar Ratio Rank
ENVB Martin Ratio Rank: 1010
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VXUS vs. ENVB - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Vanguard Total International Stock ETF (VXUS) and Enveric Biosciences Inc (ENVB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


VXUSENVBDifference
Sharpe ratioReturn per unit of total volatility

+2.52

Sortino ratioReturn per unit of downside risk

+3.74

Omega ratioGain probability vs. loss probability

1.37

0.87

+0.50

Calmar ratioReturn relative to maximum drawdown

2.86

-0.98

+3.84

Martin ratioReturn relative to average drawdown

11.00

-1.34

+12.34

VXUS vs. ENVB - Sharpe Ratio Comparison

The current VXUS Sharpe Ratio is 2.01, which is higher than the ENVB Sharpe Ratio of -0.51. The chart below compares the historical Sharpe Ratios of VXUS and ENVB, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

VXUS vs. ENVB - Drawdown Comparison

The maximum VXUS drawdown since its inception was -35.97%, smaller than the maximum ENVB drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for VXUS and ENVB.


Loading charts...

Drawdown Indicators


VXUSENVBDifference

Max Drawdown

Largest peak-to-trough decline

-35.97%

-100.00%

+64.03%

Max Drawdown (1Y)

Largest decline over 1 year

-11.27%

-91.49%

+80.22%

Max Drawdown (3Y)

Largest decline over 3 years

-13.58%

-99.81%

+86.23%

Max Drawdown (5Y)

Largest decline over 5 years

-29.44%

-100.00%

+70.56%

Max Drawdown (10Y)

Largest decline over 10 years

-35.97%

-100.00%

+64.03%

Current Drawdown

Current decline from peak

0.00%

-100.00%

+100.00%

Average Drawdown

Average peak-to-trough decline

-8.20%

-86.07%

+77.87%

Ulcer Index

Depth and duration of drawdowns from previous peaks

2.93%

66.73%

-63.80%

Volatility

VXUS vs. ENVB - Volatility Comparison

The current volatility for Vanguard Total International Stock ETF (VXUS) is 6.87%, while Enveric Biosciences Inc (ENVB) has a volatility of 21.07%. This indicates that VXUS experiences smaller price fluctuations and is considered to be less risky than ENVB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


VXUSENVBDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.87%

21.07%

-14.20%

Volatility (6M)

Calculated over the trailing 6-month period

14.09%

105.59%

-91.50%

Volatility (1Y)

Calculated over the trailing 1-year period

16.11%

175.01%

-158.90%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

16.23%

155.96%

-139.73%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

17.21%

164.65%

-147.44%

Dividends

VXUS vs. ENVB - Dividend Comparison

VXUS's dividend yield for the trailing twelve months is around 2.63%, while ENVB has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
ENVB
Enveric Biosciences Inc
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
VXUS
Vanguard Total International Stock ETF
2.63%3.18%3.37%3.24%3.09%3.10%2.14%3.06%3.18%2.73%2.93%2.83%

Frequently Asked Questions


VXUS and ENVB have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ENVB has higher volatility (21.07%) compared to VXUS (6.87%). In terms of maximum drawdown, VXUS dropped -35.97% vs ENVB's -100.00%.

VXUS currently has the higher Sharpe Ratio (2.01 vs -0.51), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for VXUS and ENVB

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer